Publication
What M&A trends will transform the 2024 insurance landscape?
It is widely accepted that 2023 was one of the worst years in recent memory for M&A activity.
Author:
Global | Publication | May 2016
Instrument: “Case Management Guidelines for NOC Applications”, further to the Patented Medicines (Notice of Compliance) Regulations, SOR/93-133 (as am.) (the Regulations)
Date released: Presented 12 May 2016 at CBA IP Day Town Hall; on the Federal Court website 20 May 2016
The Federal Court has introduced new guidelines for the case-management of prohibition applications under the Regulations. The new guidelines were presented by Chief Justice Crampton, Justice Manson, and Prothonotary Tabib at the Canadian Bar Association’s 2016 IP Day Town Hall meeting. They build upon a practice direction that has been in effect for proceedings of this kind since 7 January 2008 and outline procedures that emphasise early scheduling, strict time management, narrowing of issues, and limiting the amount of material to be reviewed by hearing judges. They also introduce a general rule that all Federal Court cases (including infringement/impeachment and section 8 actions) will be heard on a fixed-end basis.
As explained at the Town Hall, these guidelines are effective immediately and apply to all new prohibition applications, as well as ongoing matters provided they are early enough in the process.
The new guidelines are not absolute, but will be applied by case-management and hearing judges in the absence of exceptional reasons for departing from this approach. In part, they reiterate the process already defined by the Regulations and familiar to litigants today. Among the new policies introduced, the following are highlights:
To access a complete copy of the new guidelines, as well as the previous practice direction, follow the links below.
Link to guidelines:
Notice to the Parties and Profession (May 2016): Case Management Guidelines for NOC Applications
Notice to the Parties and Profession (7 December 2007): Practice Direction — NOC Proceedings
Publication
It is widely accepted that 2023 was one of the worst years in recent memory for M&A activity.
Publication
The ongoing conflicts and further geopolitical tensions in Eastern Europe and the Middle East, coupled with upcoming elections in a number of key countries including the US and the UK, make 2024 challenging to predict what impact this will have on the insurance sector.
Publication
On 6 September 2022, the European Commission (EC) prohibited Illumina’s acquisition of Grail, bringing to an end the administrative stage of a legal saga that has attracted interest beyond competition law specialists.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023